Michael H. Mulroy - Director at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LCTX on NYSE
All Insider Reports
All Insider Reports

Michael H. Mulroy - trading volume in the past year for Lineage Cell Therapeutics, Inc.

Holdings reported by Michael H. Mulroy for Lineage Cell Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 299K $169K $0.57 Nov 22, 2024 Direct
Stock Option (Right to Buy) 75K Jul 1, 2024 Direct Common Shares

Transactions reported by Michael H. Mulroy for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.